<code id='A8D125D9A2'></code><style id='A8D125D9A2'></style>
    • <acronym id='A8D125D9A2'></acronym>
      <center id='A8D125D9A2'><center id='A8D125D9A2'><tfoot id='A8D125D9A2'></tfoot></center><abbr id='A8D125D9A2'><dir id='A8D125D9A2'><tfoot id='A8D125D9A2'></tfoot><noframes id='A8D125D9A2'>

    • <optgroup id='A8D125D9A2'><strike id='A8D125D9A2'><sup id='A8D125D9A2'></sup></strike><code id='A8D125D9A2'></code></optgroup>
        1. <b id='A8D125D9A2'><label id='A8D125D9A2'><select id='A8D125D9A2'><dt id='A8D125D9A2'><span id='A8D125D9A2'></span></dt></select></label></b><u id='A8D125D9A2'></u>
          <i id='A8D125D9A2'><strike id='A8D125D9A2'><tt id='A8D125D9A2'><pre id='A8D125D9A2'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:8247
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more
          iTeos Therapeutics debuts first data on TIGIT
          iTeos Therapeutics debuts first data on TIGIT

          AdobeITeosTherapeuticsofferedthefirstlookatclinicaldataforitsexperimentalcancerantibodythatworksbybl

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo